Ongoing clinical trials of nonviral siRNA therapeutics

EA Narasipura, R VanKeulen-Miller, Y Ma… - Bioconjugate …, 2023 - ACS Publications
Short interfering RNAs (siRNA) are a powerful class of genetic medicines whose clinical
translation can be hindered by their suboptimal delivery properties in vivo. Here, we provide …

Multifunctional rolling circle transcription-based nanomaterials for advanced drug delivery

X Ma, Y Zhang, K Huang, L Zhu, W Xu - Biomaterials, 2023 - Elsevier
As the up-and-comer in the development of RNA nanotechnology, RNA nanomaterials
based on functionalized rolling circle transcription (RCT) have become promising carriers for …

Nanoengineered Polymeric RNA Nanoparticles for Controlled Biodistribution and Efficient Targeted Cancer Therapy

T Kim, HS Han, K Yang, YM Kim, K Nam, KH Park… - ACS …, 2024 - ACS Publications
RNA nanotechnology, including rolling circle transcription (RCT), has gained increasing
interest as a fascinating siRNA delivery nanoplatform for biostable and tumor-targetable …

Nucleic acid-based artificial nanocarriers for gene therapy

L Zhu, J Luo, K Ren - Journal of Materials Chemistry B, 2023 - pubs.rsc.org
Nucleic acid nanotechnology is a powerful tool in the fields of biosensing and nanomedicine
owing to their high editability and easy synthesis and modification. Artificial nucleic acid …

pH-Responsive Dynaplexes as Potent Apoptosis Inductors by Intracellular Delivery of Survivin siRNA

Y Liu, S Ashmawy, L Latta, AV Weiss, AF Kiefer… - …, 2023 - ACS Publications
Gene knockdown by siRNA offers an unrestricted choice of targets and specificity based on
the principle of complementary Watson–Crick base pairing with mRNA. However, the …

Rolling Circle Amplification-Based DNA Nano-Assembly for Targeted Drug Delivery and Gene Therapy

Z Zhang, D Xu, J Wang, R Zhang, H Du… - …, 2022 - ACS Publications
Combining the killing ability of chemotherapy drugs on tumor cells with the inhibiting ability
of genetic drugs on tumor cell growth, a dual drug delivery system loaded with therapy drugs …

[HTML][HTML] Rna-loaded nanoparticles for the treatment of hematological cancers

E Garbayo, SH El Moukhtari… - Advanced Drug Delivery …, 2024 - Elsevier
Hematological cancers encompass a diverse group of malignancies affecting the blood,
bone marrow, lymph nodes, and spleen. These disorders present unique challenges due to …

Intrinsic Synergy and Selectivity for the Inhibition of Cancer Cell Growth Generated by a Polymer Ligand of Proximal Enzymes

Y Koba, M Nakamoto, M Nagao, Y Miura… - Nano Letters, 2024 - ACS Publications
A fundamental understanding of the design of polymer ligands of proximal enzymes is
essential for the precise targeting of cancer cells, but it is still in its infancy. In this study, we …

[HTML][HTML] Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy

E Pashkina, M Bykova, M Berishvili, Y Lazarev… - Cells, 2025 - mdpi.com
In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising
biomaterial for the development of drug delivery systems. Due to its unique properties, such …

The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment

Y Liu, S Yu, Y Chen, Z Hu, L Fan… - Frontiers in Pharmacology, 2024 - frontiersin.org
Hematologic malignancies (HMs), also referred to as hematological or blood cancers, pose
significant threats to patients as they impact the blood, bone marrow, and lymphatic system …